dietary milled flaxseed flaxseed oil improve num fatty acid status affect glycemic control individuals well-controlled type pubmed ncbi abstract objective determine effects dietary consumption milled flaxseed flaxseed oil glycemic control num fatty acid status anthropometrics adipokines individuals type num diabetes design thirty-four participants randomized parallel controlled trial subjects participants adults type num diabetes age num num years body mass index num num kg/m num num men num women interventions participants consumed selection bakery products flax control group ctl num milled flaxseed fxs num g/d flaxseed oil fxo num g/d daily num weeks fxs fxo groups received equivalent amounts alpha-linolenic acid ala num g/day measures outcome primary outcome measures fasting plasma hemoglobin num glucose insulin phospholipid fatty acid composition secondary outcome measures fasting circulating leptin adiponectin body weight body mass index waist circumference dietary intake assessment calculations homeostasis model assessment insulin resistance quantified insulin sensitivity check completed results fxs fxo groups increases plasma phospholipid num fatty acids ala eicosapentaenoic acid epa decosapentaenoic acid dpa docosahexaenoic acid fxo group epa dpa plasma phospholipids compared fxs group groups similar caloric intakes ctl group experienced num weight gain compared baseline num flax groups constant body weights study period parameters including glycemic control unchanged dietary treatment conclusions milled fxs fxo intake affect glycemic control adults well-controlled type num diabetes prevention weight gain flax consumption warrants investigation 
